drugset / Trial / NCT03899454

Garcinia Mangostana L Rind and Solanum Lycopersicum Fructus Trial to Prevent Exercise-induced Oxidative Stress

NCT03899454 ↗

RandomizedParallel-groupDouble-blindTreatment

Summary

Treatments are an administration of a mixed extract of Garcinia mangostana 400mg and Solanum Lycopersicum Fructus 200mg (OKSI(R) POM TR 193324351) and placebo control.

Timeline

Start
2020-07-15
Primary completion
2020-09-15
Completion
2022-09-15

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Garcinia-mangostana-L-rind Unknown 400 mg —
Subject Solanum-Lycopersicum-Fructus Unknown 200 mg —